StockNews.com upgraded shares of FONAR (NASDAQ:FONR – Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Wednesday morning.
FONAR Trading Down 2.3 %
Shares of FONR opened at $18.00 on Wednesday. The firm has a market capitalization of $113.94 million, a P/E ratio of 11.54 and a beta of 1.19. FONAR has a 12-month low of $12.13 and a 12-month high of $24.05. The firm has a fifty day moving average price of $16.38 and a 200-day moving average price of $18.40.
FONAR (NASDAQ:FONR – Get Free Report) last released its quarterly earnings data on Wednesday, May 15th. The medical equipment provider reported $0.27 earnings per share for the quarter. FONAR had a net margin of 10.66% and a return on equity of 7.50%. The company had revenue of $25.72 million during the quarter.
Institutional Trading of FONAR
FONAR Company Profile
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.
Featured Stories
- Five stocks we like better than FONAR
- The How And Why of Investing in Oil Stocks
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- Investing in large cap stocks: Diving into big caps
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for FONAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FONAR and related companies with MarketBeat.com's FREE daily email newsletter.